However, GATA3 positivity was found in 31.5% of 476 Upk1a/Upk1b negative while Upk1a/Upk1b positivity was observed in 42.7% of 569 GATA3 negative pT2-4 cancers (Fig. 3B). This evidence concerns the gene UPK1A and cancer.